Matrix metalloproteinase-2 as a target for head and neck cancer therapy.
about
Investigation of a MMP-2 activity-dependent anchoring probe for nuclear imaging of cancerMMP-11 promoted the oral cancer migration and Fak/Src activation.A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma.Impact of VEGF-C gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.POU5F1 enhances the invasiveness of cancer stem-like cells in lung adenocarcinoma by upregulation of MMP-2 expressionTLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosisFragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13.Caffeic Acid phenethyl ester inhibits oral cancer cell metastasis by regulating matrix metalloproteinase-2 and the mitogen-activated protein kinase pathway.Antitumor effects of recombinant human adenovirus-p53 against human cutaneous squamous cell carcinoma in mice.Functional genetic variant in the Kozak sequence of WW domain-containing oxidoreductase (WWOX) gene is associated with oral cancer risk.Inhibitory effects of Leucaena leucocephala on the metastasis and invasion of human oral cancer cells.Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.Rubus idaeus extract suppresses migration and invasion of human oral cancer by inhibiting MMP-2 through modulation of the Erk1/2 signaling pathway.Hispolon suppresses migration and invasion of human nasopharyngeal carcinoma cells by inhibiting the urokinase-plasminogen activator through modulation of the Akt signaling pathway.Mesenchymal-epithelial signalling in tumour microenvironment: role of high-mobility group Box 1.Transforming growth factor-β1 induces invasion ability of HSC-4 human oral squamous cell carcinoma cells through the Slug/Wnt-5b/MMP-10 signalling axis.Pterostilbene suppresses oral cancer cell invasion by inhibiting MMP-2 expression.Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation.Radiation alters the cargo of exosomes released from squamous head and neck cancer cells to promote migration of recipient cellsHigh Level of Plasma EGFL6 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma.Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells.Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression.Melatonin as a potential inhibitory agent in head and neck cancer.Andrographolide suppresses the migratory ability of human glioblastoma multiforme cells by targeting ERK1/2-mediated matrix metalloproteinase-2 expression.Rubus idaeus Inhibits Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Suppression of MMP-2 through Modulation of the ERK1/2 Pathway.Antimetastatic effects of Rheum palmatum L. extract on oral cancer cells.Tricetin suppresses human oral cancer cell migration by reducing matrix metalloproteinase-9 expression through the mitogen-activated protein kinase signaling pathway.Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways.Expression of myeloid zinc finger 1 and the correlation to clinical aspects of oral squamous cell carcinoma.Pterostilbene Inhibits Vascular Smooth Muscle Cells Migration and Matrix Metalloproteinase-2 through Modulation of MAPK Pathway.
P2860
Q28540644-2888A4BA-BF78-49DB-8D92-91E0087157B0Q33779252-E7B8075C-01A8-40E7-91DF-7D5C1FEEA9A8Q33798500-046F2E38-E325-4935-93E2-77DBA2E5B38AQ34672891-551ACA0E-3BDD-491E-BF44-3CA5686203CBQ35080320-455F0E77-E869-4E77-BDE1-55D6F96F5FE4Q35605453-F607D523-05D1-4D7F-91C6-FDB690A904C6Q36078299-9282BA09-2F32-46A4-80D3-2AAD265AA845Q36504702-85066BA4-C942-48B2-B170-7640728A2EDFQ37582051-9D0D2DD4-1930-4718-AE23-0896497EC1A6Q37688376-782B90D5-6F75-4187-A366-DE93E7406FDFQ38717161-1229885F-0701-450C-B7BC-74E3F5C15E1EQ38725320-4EFFD052-7889-4723-847F-4B8DA2C1E063Q38763316-3DA75755-E8C7-462F-B31D-54721282130CQ38781428-228D91E9-9D2A-462D-BFE0-29708C380718Q38786090-8953728A-C99B-48A0-8FCE-9CDA6613D9A6Q38795282-95096EC9-AA8E-4566-BD32-039E1BA3B4C8Q38967409-B9C8507E-646A-4FB9-88C1-67C742396118Q40996633-467E8FC4-386C-4683-8BFE-A9FC21E459D4Q42172217-2A68BFDB-9344-4857-A35D-7E79A5B39550Q42250454-540CBFD4-8E73-4618-9187-ABD7707ABA9FQ47099030-69107D72-E09C-4743-B96A-C4C89EDE2589Q47105893-9D964114-FAA3-443A-93AC-80F1C3A0CA7BQ47112398-A7E9EA1D-C887-4A83-9F02-77F1EC334D15Q47127766-4B008D9E-C026-45E5-B523-469FB8F1CB28Q47745693-61FC4FA0-11B0-48C8-BDC8-0ECAD0F42617Q50545475-CC8160FB-2608-4457-91F5-F949E57E33A8Q50878067-EFC9BD5F-B886-4479-B114-1B841C003D7AQ51061399-571F75EC-ABF9-448C-83AC-C4414A342EBEQ53543483-00626E1B-B331-402D-A988-5957A401FF98Q55041980-3ECC0661-7D36-4D9D-8ACD-D86C04A14790
P2860
Matrix metalloproteinase-2 as a target for head and neck cancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Matrix metalloproteinase-2 as a target for head and neck cancer therapy.
@en
type
label
Matrix metalloproteinase-2 as a target for head and neck cancer therapy.
@en
prefLabel
Matrix metalloproteinase-2 as a target for head and neck cancer therapy.
@en
P2093
P2860
P1476
Matrix metalloproteinase-2 as a target for head and neck cancer therapy.
@en
P2093
Chao-Wen Cheng
Chiao-Wen Lin
Ming-Hsien Chien
Shun-Fa Yang
Yu-Ching Wen
P2860
P304
P356
10.1517/14728222.2013.740012
P407
P577
2012-12-19T00:00:00Z